Dr. Collen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8901 Rockville Pike
Pulmonary Clinic Dept of Medicine
Bethesda, MD 20889Phone+1 703-966-1598Fax+1 301-896-7330
Education & Training
- National Capital ConsortiumFellowship, Sleep Medicine, 2012 - 2013
- National Capital ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2011
- National Capital ConsortiumResidency, Internal Medicine, 2006 - 2009
- San Antonio Uniformed Services Health Education ConsortiumInternship, Surgery, 2002 - 2003
- UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2002
Certifications & Licensure
- MD State Medical License 2015 - 2026
- VA State Medical License 2010 - 2026
- DC State Medical License 2023 - 2024
- IN State Medical License 2003 - 2017
- TX State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Internal Medicine Sleep Medicine
Clinical Trials
- Vasculaire Leg Compression Device for the Treatment of Restless Legs Syndrome - A Prospective Clinical Study Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 35 citationsTreatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter.Stephen W. Olson, James D. Oliver, Jacob F. Collen, Jessica Bunin, Todd Gleeson
Critical Care Explorations. 2020-07-30 - 40 citationsObstructive sleep apnea and cardiovascular disease, a story of confounders!Jacob F. Collen, Christopher J. Lettieri, Emerson M. Wickwire, Aaron B. Holley
Sleep & Breathing = Schlaf & Atmung. 2020-01-09 - 258 citationsInhibition of Bruton tyrosine kinase in patients with severe COVID-19.Mark Roschewski, Michail S. Lionakis, Jeff P. Sharman, Joseph Roswarski, Andre Goy
Science Immunology. 2020-06-05
Professional Memberships
- Fellow
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: